Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Multicenter Study
. 2021 May;46(3):577-586.
doi: 10.1111/coa.13716. Epub 2021 Feb 4.

Admission avoidance in acute epistaxis: A prospective national audit during the initial peak of the COVID-19 pandemic

INTEGRATE (The UK ENT Trainee Research Network)
Collaborators
Multicenter Study

Admission avoidance in acute epistaxis: A prospective national audit during the initial peak of the COVID-19 pandemic

INTEGRATE (The UK ENT Trainee Research Network). Clin Otolaryngol. 2021 May.

Abstract

Objectives: To report changes in practice brought about by COVID-19 and the implementation of new guidelines, and to explore factors relating to unscheduled re-presentations for patients discharged from the emergency department (ED).

Design: Prospective multicentre national audit over 12 weeks from 6th April 2020.

Setting: UK secondary care ENT departments.

Participants: Adult patients with acute epistaxis.

Main outcome measures: Re-presentation within 10 days for patients discharged from the ED.

Results: Eighty three centres from all four UK nations submitted 2631 valid cases. The majority of cases were ED referrals (89.7%, n = 2358/2631). 54.6% were discharged from the ED following ENT review (n = 1267/2322), of whom 19.5% re-presented within 10 days (n = 245/1259) and 6.8% were ultimately admitted (n = 86/1259). 46.7% of patients had a non-dissolvable pack inserted by ED prior to referral to ENT (n = 1099/2355). The discharge rates for ED patients and their subsequent re-presentation rates were as follows: non-dissolvable packs, 29.5% discharged (n = 332/1125), 18.2% re-presented (n = 60/330); dissolvable products, 71.1% discharged (n = 488/686), 21.8% re-presented (n = 106/486); cautery only, 89.2% discharged (n = 247/277), 20.0% re-presented (n = 49/245); and no intranasal intervention, 85.5% discharged (n = 200/234), 15.2% re-presented (n = 30/198). Univariable logistic regression showed that not being packed by ED, antiplatelet medications, failed cautery and recent epistaxis treatment were significant predictors of re-presentation within 10 days.

Conclusions: Management of acute epistaxis was notably affected during the initial peak of the pandemic, with a shift towards reduced admissions. This national audit highlights that many patients who may previously have been admitted to hospital may be safely discharged from the ED following acute epistaxis.

Keywords: ambulatory; discharge; multicentre; observational; outpatient.

PubMed Disclaimer

References

REFERENCES

    1. NHS Digital. NHS Hospital Episode Statistics in England and Wales; 2017.
    1. INTEGRATE (The National ENT Trainee Research Network). Epistaxis 2016: national audit of management. J Laryngol Otol. 2017;131:1131-1141.
    1. Harcourt J, Tamin A, Lu X, et al. Severe acute respiratory syndrome Coronavirus 2 from patient with coronavirus disease, United States. Emerging Infect. Dis. 2020;26:1266-1273.
    1. Zou L, Ruan F, Huang M, et al. SARS-CoV-2 viral load in upper respiratory specimens of infected patients. N Engl J Med. 2020;382:1177-1179.
    1. Thamboo A, Lea J, Sommer DD, et al. Clinical evidence based review and recommendations of aerosol generating medical procedures in otolaryngology - head and neck surgery during the COVID-19 pandemic. J Otolaryngol Head Neck Surg. 2020;49:28.

Publication types

LinkOut - more resources